Skip to Content
Merck
CN

Key Documents

View All Documentation

EMU019801

MISSION® esiRNA

targeting mouse Pin1

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GTCCCTTCAGCAGAGGTCAGATGCAGAAACCATTTGAGGATGCGTCGTTTGCTCTACGGACAGGGGAGATGAGTGGGCCCGTGTTCACGGACTCGGGCATCCATATCATCCTGCGCACAGAATGAGGGCAGGCACCTGGCCAGCCTGCTCTGGCTGCCACACAGCCCACGGATGCCCTTCCTGCTACTGTCACACAGTATTTATTGTTCCTAAAATGACTGGGAGGGGCTCTGAGCATCCCGCTCCCTGTTTGCCCCTATTCGGGGCTGTCCTAGCCAGGCTCCTTCTGGAGGAATTGACTTCAGAAGGGCAGTGGGGATGGGGAGGCCCCCAGGCTCAGGGGGTCAGAGGTGACCTGATCCCCCAGGTCTCAGAGGCAGGCAGGAGGGCCTTCTTTCTTGTTAGTTATATGCTCCATTCGTTCCTCTGTTCAGTTGCA

Ensembl | mouse accession no.

ENSMUSG00000032171

NCBI accession no.

NM_023371

shipped in

ambient

storage temp.

−20°C

Gene Information

mouse ... PIN1(23988), Pin1(23988)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
QCS
NBT

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ryuhei Kanaoka et al.
PloS one, 10(6), e0127467-e0127467 (2015-06-04)
Prostate cancer initially develops in an androgen-dependent manner but, during its progression, transitions to being androgen-independent in the advanced stage. Pin1, one of the peptidyl-prolyl cis/trans isomerases, is reportedly overexpressed in prostate cancers and is considered to contribute to accelerated

Global Trade Item Number

SKUGTIN
EMU019801-20UG04061831345643
EMU019801-50UG04061828278442